about
Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSATreatment for bacteraemia due to Staphylococcus aureusTreatment for bacteraemia due to Staphylococcus aureusClinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort StudyImpact of Bacterial and Human Genetic Variation on Staphylococcus aureus InfectionsDusp3 and Psme3 are associated with murine susceptibility to Staphylococcus aureus infection and human sepsisGene expression-based classifiers identify Staphylococcus aureus infection in mice and humansStaphylococcus aureus bacteraemia in a tropical setting: patient outcome and impact of antibiotic resistancePotential associations between severity of infection and the presence of virulence-associated genes in clinical strains of Staphylococcus aureusTwo genes on A/J chromosome 18 are associated with susceptibility to Staphylococcus aureus infection by combined microarray and QTL analysesDelays in appropriate antibiotic therapy for gram-negative bloodstream infections: a multicenter, community hospital studyCritical role of NOD2 in regulating the immune response to Staphylococcus aureusPanton-Valentine leukocidin is not the primary determinant of outcome for Staphylococcus aureus skin infections: evaluation from the CANVAS studiesTransmission of MRSA between companion animals and infected human patients presenting to outpatient medical care facilitiesWhole Genome Sequencing of a Methicillin-Resistant Staphylococcus aureus Pseudo-Outbreak in a Professional Football Team.A host-based RT-PCR gene expression signature to identify acute respiratory viral infectionOsteoblasts produce monocyte chemoattractant protein-1 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue.Staphylococcus aureus infections following knee and hip prosthesis insertion procedures.Antibacterial resistance leadership group: open for business.Multiplex PCR to diagnose bloodstream infections in patients admitted from the emergency department with sepsis.Geographic Expansion of Lyme Disease in Michigan, 2000-2014.Phenotypic and genotypic characteristics of persistent methicillin-resistant Staphylococcus aureus bacteremia in vitro and in an experimental endocarditis model.A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study.Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network.Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) functionBonds between fibronectin and fibronectin-binding proteins on Staphylococcus aureus and Lactococcus lactisStaphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studiesGenetic variability in beta-defensins is not associated with susceptibility to Staphylococcus aureus bacteremiaA tactile response in Staphylococcus aureus.Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infectionsEmerging and resistant infectionsIntegrative "omic" analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromesInfective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the YClinical management of Staphylococcus aureus bacteremia: a review.Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 studyCombinatorial phenotypic signatures distinguish persistent from resolving methicillin-resistant Staphylococcus aureus bacteremia isolates.Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.Host gene expression profiling and in vivo cytokine studies to characterize the role of linezolid and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA) murine sepsis model.Non-HACEK gram-negative bacillus endocarditis.An integrated transcriptome and expressed variant analysis of sepsis survival and death.
P50
Q22305769-17651668-B395-46CE-9706-1A8CB141BE50Q24234919-B89730BB-4281-4679-B0F9-3A9AF5483979Q24241085-D6987A54-CD66-4DE2-AF8A-F789A1847243Q24634085-4E0943DB-61F8-4FEF-B93D-9025F7AE50C7Q26772043-8DC13083-3345-4540-A527-D17E086E1D67Q27325556-CF135854-081B-4002-8684-457DD488F7F4Q27339671-A5E274A5-8371-4139-A749-6B8C16B04D47Q28474630-59A75D76-900D-41E9-B43C-7A7E209D4268Q28477896-69CFB246-64CA-4607-AFE9-E5B159FEFAD1Q28512431-749995AD-AC1E-43C3-B841-4B0883DF0DD0Q28534034-CE95A128-1F18-4CC7-A4DF-CE58299F8D05Q28593011-D4B4F859-8E5E-475D-80F0-35424CF622A9Q28729864-8BC8D850-0F0C-48AC-AC50-3B4A61E35685Q28742924-FEDC630F-F4A2-48E6-BED3-57A1003FA080Q30300472-26B861DC-5E8F-43B0-9F25-CB7192CE0E09Q30353712-EC4399B5-A1D7-4603-9C9E-3A899477FE92Q33219809-5B9E1FF9-F7F9-492B-8EB4-DDABD577748AQ33576923-6D2AA796-9BA5-4C1D-BB2E-2D4257A3587AQ33598252-6ABF81F0-9B19-4DA9-A801-29F9AE070926Q33614220-118C6DC9-58F7-4F27-89D4-13DF21DDC083Q33625348-E3DB8E5D-80D5-4E6E-8106-C63DF6A02A3FQ33683520-05BCDD33-12B6-4560-B77D-6527B444286EQ33723124-184C8100-C2BF-48B3-932E-388F4FE4303CQ33798238-3F2028BF-BCBE-46F9-A37F-18BDBE851F4CQ33883752-4120409F-3C1C-4E09-8B85-F106F37E0CECQ33947017-D21BE678-3C10-4B03-B4C2-165B4CC4019CQ34060175-96CB8915-5A5B-44A3-BB1D-DA06A9097507Q34182520-F5522163-1DA3-4795-93D8-45D294711681Q34250536-9BEFE9AC-6739-45DE-B958-D0B5BB030D97Q34354252-5B6FD55C-30A6-4B66-9AB6-F5D8B801A491Q34357419-DF00DD6A-9A05-4BC2-AEC2-C431CB370601Q34425990-65C9D983-EAFF-41C0-A6AE-F7C51CF2DEE5Q34426508-E91C0591-8F8D-4DD0-9D30-EDBC87794CCCQ34441035-CBE856B2-86FD-490C-8A29-DB661B5DD55DQ34509652-7B6B615F-E1B9-48B9-9250-F85D767C959AQ34529085-AD43BA5B-01F2-492A-A479-C018CD918D2EQ34558111-36729FD8-BC03-4CD6-8223-403F81FF502BQ34658467-05D24D8F-AA3A-4A09-B280-3218BDE22E08Q34726790-DE1958D7-6E7E-492A-A514-3056F756BD59Q34762245-3ECF82E8-8173-4CE1-9DBA-9CD0E157C1F4
P50
name
Vance G Fowler
@ast
Vance G Fowler
@en
Vance G Fowler
@nl
type
label
Vance G Fowler
@ast
Vance G Fowler
@en
Vance G Fowler
@nl
prefLabel
Vance G Fowler
@ast
Vance G Fowler
@en
Vance G Fowler
@nl
P214
P214
P31
P734
P7859
lccn-n2012188922